Figure S3 from Single-Cell Immune Competency Signatures Associate with Survival in Phase II GVAX and CRS-207 Randomized Studies in Patients with Metastatic Pancreatic Cancer

Abstract

Manual gating verification of immune cell subsets associated with clinical outcome at baseline, 7-and 10- weeks post treatment in the phase 2a training set